Mild phenotype of Molybdenum cofactor (MoCo) deficiency Type B among Egyptian patients
Last updated: 05 Jan 2025
10.21608/MXE.2023.283880
GPHN, MoCS1, MoCS2, MoCS3 genes, molybdenum cofactor, neurodevelopmental delay, prenatal genetic diagnosis, whole exome sequencing
Hisham
Megahed
Department of Clinical genetics, Institute of Human Genetics and Genome Research, National Research Centre, Cairo, Egypt.
Engy
Ashaat
A.
Department of Clinical genetics, Institute of Human Genetics and Genome Research, National Research Centre, Cairo, Egypt.
Samira
Ismail
Department of Clinical genetics, Institute of Human Genetics and Genome Research, National Research Centre, Cairo, Egypt.
Neveen
Ashaat
A.
Department of Molecular Genetics, Ain Shams University, Cairo, Egypt.
Vincent
Cantagrel
Laboratory of Molecular and Pathophysiological Bases of Cognitive Disorders, Paris, France.
Mona
El Ruby
O.
Department of Clinical genetics, Institute of Human Genetics and Genome Research, National Research Centre, Cairo, Egypt.
11
1
39416
2022-01-01
2023-02-06
2022-01-01
29
37
2090-8571
2090-763X
https://mxe.journals.ekb.eg/article_284259.html
https://mxe.journals.ekb.eg/service?article_code=284259
284,259
Original Article
2,549
Journal
Middle East Journal of Medical Genetics
https://mxe.journals.ekb.eg/
Mild phenotype of Molybdenum cofactor (MoCo) deficiency Type B among Egyptian patients
Details
Type
Article
Created At
29 Dec 2024